OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.08
+7.17%Margins
Gross margin
99.3%
EBITDA margin
-178.6%
EBIT margin
-181.4%
Net margin
-184.6%
FCF margin
-184.8%
-200.6%
Return on equity
-51.0%
Return on assets
-57.9%
Return on invested capital
0.30x
Asset turnover
-$58.3M
Cash from operations
$1.83
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026